Cochrane Airways works with authors (typically clinicians and researchers) to produce systematic reviews on asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and other lung diseases. Cochrane Airways is part of Cochrane. Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health.
Cochrane Airways was formed in 1995 and is based at St George’s, University of London, but our editorial team is international. We have published over 330 Cochrane Systematic Reviews and usually have around 40 active protocols.
Cochrane Reviews aim to address a clinical question such as “Is giving reliever inhalers through a spacer as effective as delivering them through a nebuliser for people having an asthma attack?” The clinical question is considered carefully and a strategy prepared for answering that question – this is then written up into a ‘protocol’ and peer reviewed by experts and consumers before publication. Our information specialist provides a list of potentially useful randomised controlled trials (RCTs) for the author team to assess for inclusion. A review is prepared based on the relevant trials. The editorial team organises peer review to check that that the reviews are accurate and fair.